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Introduction: Cardiac function is modulated by multiple factors including exogenous
(circadian rhythm) and endogenous (ultradian 90–110min sleep cycle) factors. By
evaluating heart rate variability (HRV) during sleep, we will better understand their
influence on cardiac activity. The aim of this study was to evaluate HRV in the dark phase
of the circadian rhythm during sleep in healthy children and adolescents.
Methods: One 3min segment of pre-sleep electrocardiography (EEG) and 3, 6min
segments of electrocardiography recorded during polysomnography from 75 healthy
children and adolescents were sampled during progressive cycles of slow wave sleep
(SWS1, SWS2, SWS3). Three, 3min segments of rapid eye movement sleep (REM) were
also assessed, with REM1marked at the last REM period before awakening. Studies that
recorded REM3 prior to SWS3 were used for assessment. HRV variables include the
following time domain values: mean NN (average RR intervals over given time), SDNN
(Standard Deviation of RR intervals), and RMSSD (root Mean Square of beat-to-beat
Differences). Frequency domain values include: low frequency (LF), high frequency (HF),
and LF:HF.
Results: Mixed linear effects model analysis revealed a significant difference in
time and frequency domain values between sleep cycles and stages. Mean NN
was lowest (highest heart rate) during pre—sleep then significantly increased across
SWS1-3. Mean NN in SWS1 was similar to all REM periods which was significantly
lower than both SWS2 and SWS3. SDNN remained at pre-sleep levels until SWS3,
and then significantly increased in REM1&2. There was a large drop in LF from
pre-sleep to SWS1. As cycles progressed through the night, LF remains lower
than awake but increases to awake like levels by REM2. RMSSD and HF were
lowest in pre-sleep and increased significantly by SWS1 and remain high and stable
across stages and cycles except during the REM3 period where RMSSD decreased.
Kontos et al. HRV Changes During Child Sleep
Conclusion: Our results demonstrate that there are considerable changes in the
spectral analysis of cardiac function occurring during different sleep stages and between
sleep cycles across the night. Hence, time of night and sleep stage need to be considered
when reporting any HRV differences.
Keywords: heart rate variability, children, sleep, circadian rhythm, ultradian rhythm
INTRODUCTION
Cardiac function and regulation is complex and involves multiple
factors that influence the timing (chronotropy) and contractile
force (ionotropy) of cardiac muscle tissue (1). Broadly the
factors can be divided into those which are (1) organ specific
(the composition–muscle fiber/connective tissue) and basal
metabolic state (cell size/connectivity) of the cardiac muscle
tissue) and (2) those which operate on the cardiovascular system
(e.g., exogenous factors such as light exposure and ambient
temperature and endogenous factors such as central pattern
generators) and activate afferent pathways or influence central
neural networks and reflex circuits needed to maintain metabolic
functioning, homeostasis and permit adaptive behaviors such
as digestion and sleep (1–3). These latter influences on cardiac
function can be assessed using heart rate variability, a commonly
usedmathematical manipulation of the electrocardiogram signal.
Both linear and non-linear techniques have been developed
to determine HRV parameters such as variance in the cardiac
timing including the average RR intervals over given time (mean
NN), Standard Deviation of RR intervals (SDNN), and root
Mean Square of beat-to-beat Differences (rMSSD). Variance
in the power distribution across the frequency range is also
calculated using Fast Fourier transforms to determine changes
in low frequency (LF, 0.15–0.40Hz) and high frequency (HF,
0.03–0.15Hz) heart beat regularity. These variables have been
proposed to be indicators of the relative tone of the two arms
of the autonomic nervous system, the parasympathetic (HF)
and sympathetic nervous systems (LF) and hence sympathovagal
activity (LF:HF) acting directly on the cardiac tissue (3–5).
More recent evaluation of the frequency domain parameters
suggests that all frequency domain variables (LF, HF, and LF:HF)
are more likely to represent parasympathetic drive alone (6)
especially LF in the supine position during paced breathing (7).
It has also been postulated that LF and oscillations in the 0.1Hz
range represent vagal control of the baroreflex (8). In support of
this hypothesis are studies which show that manipulation of the
baroreflex response alone demonstrates a positive correlation in
LF power while manipulation of the sympathetic innervation to
the cardiac tissue does not alter LF power (6, 8).
Sleep is a time where there is considerable change in the
cardiac function and in vascular tone of cutaneous vessels and
thermoregulation (9, 10). Hence by investigating HRV during
sleep where we know there are dynamic changes occurring both
in cardiac function and vascular compliance across the night,
we may better understand the genesis of the different HRV
parameters in the ECG signal.
Occurring in the dark phase of the circadian cycle the
propensity to sleep increases in humans after core body
temperature reaches its peak (acrophase∼2,100 h) and then body
temperature begins to fall (11, 12). Upon sleep onset, sympathetic
tone to the musculature decreases while cardiac parasympathetic
activity/vagal tone increase and heart rate decreases (13). This
is paralleled by a drop in blood pressure and an increase in
peripheral vasculature dilatation to cutaneous vessels to dissipate
heat (11, 14). As sleep progresses, and core body temperature
reaches its lowest point across the dark phase (nadir 0300–0500),
the processes reverse and sleep propensity decreases, and body
temperature and heart rate then begin to rise before wake (9).
This latter change is coupled with a reduction in peripheral
vascular compliance which is proposed to occur in order to
increase core and brain temperature to facilitate arousal and
awakening. Hence vascular compliance plays a large role in sleep
propensity and the dark phase of the circadian cycle. Whether
LF (as a potential marker of baroreflex/vascular compliance)
also follows the change in peripheral vascular compliance and
whether this trend is also evident in vagal measurements involved
in cardiac timing (mean NN, SDNN, and RMSSD) and HF at the
same time has not been addressed in the literature.
Superimposed on the dark phase of the circadian cycle is a
90–110min ultradian rhythm consisting of two distinct sleep
stages [non-rapid eye movement sleep (NREM) and rapid eye
movement sleep (REM)] (15). Heart rate also demonstrates
characteristic ultradian rhythmic changes with slower heart
rate in NREM (16), especially in NREM3/4—known as slow
wave sleep (SWS) and higher rates in REM (17). Although the
mechanisms governing the control of ultradian rhythmicity are
not fully understood, it is well-accepted that the autonomic
nervous system and its control on both the cardiac tissue and
peripheral vasculature are major contributors to the ultradian
changes in cardiac function observed during sleep (18).
By investigating the changes inHRV variables in stable periods
of sleep across the night where we know that there is a circadian
change in body temperature and where the largest difference in
frequency and amplitude in the EEG signals are reported (REM
and SWS) and hence evidence of the peak and trough of each
individual sleep cycle across the night are evident, we may better
understand the relationship of HRV variables and the physiology
of sleep. This study therefore aims to examine the effects of time-
of-night and sleep stage (SWS vs. REM) on HRV parameters in a
cohort of healthy children and adolescents.
METHODS
Subjects
The polysomnographic (PSG) data of 118 children aged
3.1–15.1 years, who had previously participated, as healthy
control children from the community, in three sleep
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projects, through the Women’s and Children’s Hospital,
Sleep Disorders Unit were analyzed in this study (19–
21). Parental questionnaires of the child’s health and the
results of the PSG confirmed their status as non-snoring,
healthy children. Height was measured using a wall mounted
stadiometer and weight was measured using a digital scale
with a resolution of 0.1 kg. Body mass index, percentile and
exact age at testing were calculated using a website algorithm
(http://www.bcm.edu/cnrc/bodycomp/bmiz2.html).
Polysomnography
The Compumedics Sleep Systems (Melbourne, Australia) was
used to collect electroencephalograhic (EEG), left and right
electro-oculographic (EOG), sub-mental and diaphragmatic
electromyographic (EMG) data. Leg movement was assessed
by electromyography, heart rate by electrocardiogram (ECG),
oro-nasal airflow by thermistor and nasal pressure, respiratory
movements of the chest and abdominal wall using uncalibrated
respiratory inductive plethysmography (RIP) and arterial oxygen
saturation (SaO2) by pulse oximetry (Nellcor N-595; 2 s averaging
time). Children were continuously monitored via infrared
camera by a pediatric sleep technician who also documented
observations of sleep behavior, which included the presence
or absence of snoring. All sleep studies were conducted
in the same environment at the same ambient temperature
throughout sleep.
Electrocardiographic Recordings
The overnight ECG signals which were sampled at a rate of
512Hz, were used to determine HRV values.
Stage Choice and Segment Length
Pre-sleep HRV values were derived from a single segment of
ECG data taken 3min just prior to sleep onset. Segments of SWS
and REM sleep were chosen for analysis because of the reported
relative difference in stability of the EEG, ECG signals and
respiratory rate. Sleep stages are not homogenously distributed
throughout sleep, with more SWS in the beginning of sleep
and REM more prevalent in the later hours, closer to awaking
(9). Also, the time spent in each stage is significantly different
with longer time spent in SWS compared to REM sleep. To
ascertain the HRV in the most vegetative state (no movement
artifact) and to maximize the number of recordings that could
be considered we chose three clear consecutive segments from
sleep onset of 6min lengths each to analyze during SWS and
three consecutive segment taken of 3min lengths each during
REM sleep. Although long term HRV measurements (e.g., 24 h
Holter recordings) are considered predicative of pathology (22)
the aim of this study was to look at the most stable cardiac signal,
independent of the influence that other factors can contribute
to changes in the cardiac signal such as exercise/movement,
respiratory rate, ambient temperature fluctuations, food/drink
consumption and changes in physical exertion. HRV parameters
we have chosen to investigate can be evaluated using both
short and ultra-short measurements (1 × 3min Pre-sleep, 3
× 6min of SWS, and 3 × 3min REM) (22) especially if
the participant is stationary and there is little variability in
heart rate over the segment (23). Stage 2 NREM was not
analyzed as the processes that drive Stage 2 ascending into Stage
3/4 and Stage 2 descending from a period of Stage 3/4 are
unlikely to be the same and may confound the interpretation of
the results.
Each segment was identified with a number corresponding to
its timing in the sleep cycle, e.g., SWS1 (first SWS, early sleep),
SWS2 (second SWS) etc. REM segments were labeled in reverse
with the last REM stage (closest to morning wake time) recorded
as REM1, REM2, and REM3 (Figure 1). The latter occurred
closer to the middle of total sleep. So that we captured SWS and
REM stages in a consistent pattern across the night we only used
recording where REM3 preceded SWS3 for analysis. Therefore
data included were taken as follows: SWS1, SWS2, REM3, SWS3,
REM2, REM1.
When a corresponding sleep stage did not have a clear
sequence of uninterrupted sleep containing no movement or
respiratory events (apnea, hyponea, and snoring), then no data
was recorded for that cycle, e.g., some participants only have
recordings for SWS1 and SWS2 but not SWS3, etc.
Heart Rate Variability Analysis
For HRV analysis, QRS locations were automatically detected
in the ECG channel of PSG using Alfonso’s filterbank algorithm
(24). Tachograms of RR time series were visually scanned
for artifacts. Segments with artifacts were excluded from
analysis. The HRV variables were computed in accordance with
Task Force recommendations using MatLab (25). Frequency
domain analysis was conducted on RR time series interpolated
at 250ms using the Fast Fourier Transform. We examined
the low frequency component of the spectrum analysis
(0.03–0.15Hz), which is reported to correspond to the
baroreflex control of blood pressure/vascular compliance.
The primary effect of the baroreflex is on total peripheral
FIGURE 1 | Tachnograms in temporal order from a male participant (8.25 y, BMI 17.6), during SWS1, SWS2, REM3, SWS3, REM2, and REM1.
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resistance via the rostral ventral lateral medulla activation
or inhibition of sympathetic vasoconstrictor neurons (26).
We also evaluated the high frequency (HF) component of
the spectrum analysis (0.15–0.40Hz), which is reported to
correspond to the vagal control of heart rate and the oscillations
induced by respiratory activity and is, therefore, a marker
of parasympathetic activity (22). Spectral bands were chosen
according to Task Force standards. It is possible that some
of the HF power may have been excluded in very small
children due to higher breathing rates (>0.4Hz). Time domain
analyses of HRV were also undertaken with the root Mean
Square of the Successive Differences between neighboring RR
intervals (rMSSD) thought to be indicative of vagal mediated
changes in HRV and correlates with HF but less effected by
respiratory changes and standard deviation of the inter-beat
interval of normal sinus beats (SDNN) indicative of both
sympathetic and parasympathetic activity, SDNN correlates
with LF. Short term recording in resting conditions reflect
parasympathetic mediated respiratory sinus arrhythmia
(RSA) (22).
Data Analysis
To corroborate parental report of normal sleep in the cohort, the
PSG results were used to objectively determine that children did
not have an underlying sleep condition (e.g., sleep disordered
breathing). An experienced sleep technician scored the studies
according to standardized sleep stage protocol by Kales and
Rechtschaffen (27) and pediatric ventilatory criteria set by
the American Association of Sleep Medicine (28). A mixed
linear effects model analysis was performed to account for
repeated measurements for HRV variables and cycles (SWS1-
3 and REM1-3, fixed effects) and pairwise comparisons using
the fixed effect model were used to determine within subject
variability between pre-sleep and sleep cycles (7 levels) using
SPSS, version 24. Unstructured repeated covariance type was
used. Age, BMIz score and gender were correlated with
each individual HRV variable (average of 7 values presleep,
SWS1-3, REM1-3) to determine if there was an association
between variable that would need to be considered as covariates
in the mixed-model analysis. Post-hoc comparisons using
Bonferroni Correction were performed to determine within
subject differences between sleep cycles with a p < 0.05
considered significant.
RESULTS
Anthropometric and Sleep Values
Of the initial 118 children, the REM3 period preceded the SWS3
period in 75 children. Hence the data present is from those
children (50 females and 25 males) as SWS3 preceded REM3
in 42 recordings. Preliminary analyses indicted no significant
gender differences in any anthropometric and sleep value.
Anthropometric and sleep cycles onset HRV values are reported
in Table 1.
TABLE 1 | Minimum, maximum and mean (SD) anthropometric and sleep values
(75 children).
Anthropometrics Mean (SD) Minimum Maximum
Age (y) 8.5 (2.6) 3.1 13.2
Height (cm) 130.3 (16.3) 89.0 192.0
Weight (kg) 30.8 (11.7) 13.0 82.7
BMI (age and gender adjusted) 17.6 (2.6) 13.4 26.8
BMI z-score 0.4 (0.8) –1.6 2.2
Sleepa
Sleep onset time (h:min) 21:40 (0:42) 20:01 23:53
SWS1 onset time (h:min) 22:58 (1:08) 21:07 23:51
SWS2 onset time (h:min) 24:44 (1:31) 21:10 02:47
REM3 onset time (h:min) 01:39 (1:13) 23:09 03:31
SWS3 onset time (h:min) 02:40 (1:39) 21:51 05:21
REM2 onset time (h:min) 03:26 (1:23) 23:14 05:54
REM1 onset time (h:min) 05:01 (1:17) 01:15 07.52
aSWS, slow wave sleep. SWS cycles are labeled relative to initial sleep onset: SWS cycle
after sleep onset = 1st SWS, SWS cycle after sleep onset but one = 2nd SWS and SWS
cycle after sleep onset but two = 3rd SWS cycle. REM, rapid eye movement sleep. REM
cycles are labeled relative to sleep offset: REM cycle prior to sleep offset = REM1, REM
cycle preceding sleep offset but one = REM2 and REM cycle preceding sleep offset but
two = REM3 (see Figure 1).
Heart Rate Variability: Sleep Stage and
Sleep Cycle
To determine if any of our variables are related to age, gender or
BMIz, we conducted Pearson correlations between these variables
and averaged HRV variables. There were no correlations between
our averaged variables and the age, gender or BMIz and hence
covariance was not required for analysis. Mean and standard
error in HRV values are provided in Table 2. Mean differences
and standard error in HRV values are in Table 4.
Time Domain Variables
The test for fixed effects, revealed a significant main effect for
sleep cycle (Table 3). Mean NN, was significantly lower in pre-
sleep compared to all other sleep cycle/stages. While asleep
mean NN in SWS1 and all REM periods were similar and
significantly lower (higher heart rate) compared to SWS2 and
SWS3 (Tables 2–4). SDNN was similar in pre-sleep and all SWS
cycles and REM3 but increased significantly in REM1 and REM2
(Tables 2–4). RMSSD was also lowest in pre-sleep compared to
all cycles and stages (Tables 2–4). Apart from a drop in REM3,
RMSSD was stable across the night regardless of sleep stage (see
Figure 2).
Power Domain Variables
The test for fixed effects revealed there was a significant difference
between cycles (Table 3). LF significantly dropped by half from
pre-sleep to SWS1 and remained low as the night progressed
regardless of stage (SWS2, SWS3, and REM3 not significantly
different). The largest increase occurred in REM2 (see Table 4)
returning to pre-sleep like values by REM1.HFwas lowest during
pre-sleep and doubled by SWS1 and continued to remain higher
regardless of stage or time of night. LF:HF significantly reduced
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Time domain variables Power domain variables
Mean NN SDNN rMSSD LF_FFT HF_FFT LF:HF
21:40 Pre-sleep 704.6 (9.4) 55.9 (3.7) 48.1 (4.6) 1440.8 (388.0) 944.6 (139.6) 1.83 (0.24)
22:58 SWS1 775.7 (10.3) 56.1 (4.1) 68.8 (5.5) 639.4 (94.7) 1768.5 (294.9) 0.68 (0.09)
24:44 SWS2 809.4 (11.5) 57.9 (4.0) 70.8 (5.9) 750.3 (91.5) 1974.8 (346.0) 0.69 (0.07)
01:39 REM3 754.7 (11.1) 62.6 (4.3) 61.8 (5.9) 937.3 (170.8) 1483.1 (364.5) 1.16 (0.12)
02:40 SWS3 824.6 (13.0) 59.7 (4.5) 71.5 (6.7) 922.3 (148.9) 2059.8 (370.1) 1.06 (0.20)
03:26 REM2 772.9 (11.2) 71.6 (5.2) 74.0 (7.3) 1501.2 (243.2) 2299.4 (264.6) 1.82 (0.30)
05:01 REM1 763.7 (10.4) 68.2 (4.3) 67.1 (5.9) 1316.7 (235.4) 2020.5 (377.1) 1.91 (0.26)
Note: Although Stage 3 and 4 are combined for reporting purposes, we restricted our SWS analysis to Stage 4 sleep (Standard Deviation).
SWS, slow wave sleep. SWS cycles are labeled relative to sleep onset: SWS cycle after sleep onset = 1st SWS, SWS cycle after sleep onset but one = 2nd SWS and SWS cycle after
sleep onset but two = 3rd SWS cycle. REM, rapid eye movement sleep. REM cycles are labeled relative to sleep offset: REM cycle prior to sleep offset = REM1, REM cycle preceding
sleep offset but one = REM2 and REM cycle preceding sleep offset but two = REM3 (see Figure 1).
TABLE 3 | Fixed effects values for sleep cycle.
Heart rate variability variable Sleep cycle
Mean NN F (6,60.5) = 40.8, p < 0.001
SDNN F (6,56.3) = 3.7, p < 0.004
rMSSD F (6,59.5) = 3.9, p < 0.003
LF F (6,41.6) = 6.7, p < 0.001
HF F (6,58.0) = 3.2, p < 0.01
LF:HF F (6,55.6) = 9.5, p < 0.001
from pre-sleep to SWS1 and similar to LF continued to increase
as the night progressed independent of sleep stage.
DISCUSSION
The present findings indicate that HRV parameters in healthy
children and adolescents vary throughout the sleep/wake cycle
and between sleep stages. Children/adolescents can have the same
heart rate and very different timing and power HRV variables,
depending where the cycle is positioned across sleep. HRV values
can be similar or higher than pre-sleep levels in REM sleep,
yet heart rate is not the same or higher. These differences may
arise from modifying factors that are part of the patterned effect
that drive sleep propensity and sleep behavior. Furthermore,
the outcome of the mixed model analysis supports that this
phenomenon in HRV is independent of age in children and
adolescents aged 3–13 years.
Similar to results in adults (29) and children (30), we showed
that the most significant drop in heart rate (increase in mean
NN) occurs between sleep onset and SWS1 and continues to
drop only in SWS cycles as time asleep progresses. Unlike
Baharav et al. who in 10 children and adolescents showed no
difference in heart rate between sleep stages (31), we showed
that heart rate (mean NN) was significantly different between
some SWS periods and REM sleep periods across the night but
that all sleep stage cycles were not the same in uninterrupted
sleep. For example the first SWS (SWS1) cycle reported a
similar mean NN to all REM cycles, with the lowest mean
NN and highest heart rate recorded during REM3. However,
mean NN was significant higher (heart rate lower) in SWS2
and SWS3 compared to SWS1 and all REM periods. Of
significance is the dramatic difference in cardiac cycle length (7
beats per minute) between SWS3 and REM3 which occurred
approximately an hour apart in most children. What drives
these changes in heart rate is difficult to ascertain from our
data, however we suspect this may be evidence of an ultradian
biorhythm in heart rate (32) that is reported to be autonomic
in origin.
SDNN, considered a composite of all factors that contribute
to HRV (33), remained similar to pre-sleep levels in all
SWS cycles and REM3 but significantly increased by REM2
and REM1. The pre-sleep measurements were extracted from
the signal 3min prior to the sleep onset time, which was
determined using the EEG signals, and the Rechtschaffen and
Kales rules. Heart rate was highest and mean NN was lowest
during pre-sleep yet SDNN, a marker of autonomic modulation,
was at its lowest. Most children had been resting supine in
their bed for more than 10min before they fell asleep. It
is proposed that variations in SDNN during short resting
recordings reflects parasympathetically-mediated respiratory
sinus arrhythmia especially during slow paced breathing protocol
(33). This relaxation time andmore paced breathingmay account
for the reduction in SDNN prior to sleep onset. However, one
would think that heart rate would also decrease in a similar
manner if this was indeed the case. Our data suggests whatever
parameter that increases SDNN “reactivates” in the early hours
of the morning before wake. As SDNN during REM3 and SWS3
were almost identical, it is unlikely that changes in SDNN
during sleep are driven by the same mechanisms associated
with sleep staging, e.g., ultradian fluctuations as the case of
mean NN.
SDNN is best measured over 24 h recording as they
provide data on cardiac response to environmental stimuli.
However, using SDNN in short segments at times where we
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TABLE 4 | Mean (Standard Error) differences between heart rate variability values
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*Denotes p < 0.05, **p < 0.01, and ***p < 0.001 (significant differences are bolded).
SWS, slow wave sleep. SWS cycles are labeled relative to initial sleep onset: SWS cycle
after sleep onset = 1st SWS, SWS cycle after sleep onset but one = 2nd SWS and SWS
cycle after sleep onset but two= 3rd SWS cycle. REM= rapid eye movement sleep. REM
cycles are labeled relative to sleep offset: REM cycle prior to sleep offset = REM1, REM
cycle preceding sleep offset but one = REM2 and REM cycle preceding sleep offset but
two = REM3 (see Figure 1).
know there are physiological changes that are not related
to movement and mental stress, but are associated with
“autonomic change” we might better understand the base
level of the autonomic input (22). The increase in SDNN
in the REM periods just before waking may reflect the
increase in heart rate (reduced mean NN) however it does
not explain the increase in heart rate (reduced mean NN)
during REM3 where SDNN is similar to the subsequent SWS3
and where the mean NN is the highest (lowest heart rate).
Irregular respiratory rate is more prominent during REM
sleep compared to SWS where respiratory rate is stable and
respiratory rate is slower. Irregular respiratory rate may account
for the increase in REM periods, but doesn’t explain the
similar SDNN in REM3, which suggests respiratory stability
was conserved.
RMSSD is a measure of the beat-to-beat difference in heart
rate and both rMSSD and HF are considered indicators of
vagal input in HRV (22) and increases in either variable
indicate increase parasympathetic tone to the cardiac tissue.
Both measures were lowest before sleep onset but increased
significantly during SWS1. As sleep progressed, rMSSD values
remained constant regardless of stage and time of night except
during REM3 where it reduced but not to pre-sleep levels. HF
remained at the same level across the night. If rMSSD and/or HF
reflect the activity of the vagal efferents then our data suggests
that there is a large increase in vagal activity once sleep onsets, not
before. Conversely, given the large reduction between pre-sleep
SDNN and SDNN in REM periods the change in rMSSD/HF
may reflect a disengagement of sympathetic efferents to cardiac
tissue, which may reveal the optimal resting vagal input that
remains stable across sleep. Our results also imply that in children
and adolescents the vagal input is less effected by ultradian
cycling and possibly even independent of the circadian influence.
The significant reduction in rMSSD we observed during REM3
may be an indicator of the influence of circadian oscillator
however the drop in rMSSD did not continue in subsequent
cycles, which is what we would have expected to occur if the
vagal measurements were influenced by the circadian pacemaker
coming into the early hours of the morning. The drop in rMSSD
in REM3may result from a reduction in vagal cardiac innervation
(or increase in sympathetic innervation) and is consistent with
an increased heart rate and decrease mean NN at that same
time, which is what occurred. Whether this a part of a centrally
mediated program of the circadian cycle or an anomaly of the
results needs to be further investigated.
The physiological implications of LF have been proposed
to reflect baroreflex, and vascular compliance during rest
(6, 8, 34) and not cardiac sympathetic innervation (35) as
previously suggested (36). Although we have not measured
vascular resistance directly during sleep we have measured sleep
stages and the position of the cycle across the dark phase of
the circadian cycle, which are documented times related to
different vascular states (37) (SWS1 and 2, which occur early
in the night and are associated with vasodilation, and REM1
and 2, which are stages that occur closer to wake time and
are associated with significant vasoconstriction). Our LF results
may demonstrate the activation of vasomotor pathways to the
peripheral vessels and in particular cutaneous vasculature that
may be required to initiate behaviors specifically associated with
sleep (10). Inhibition of sympathetic vascular innervation to
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FIGURE 2 | Mean heart rate variability values across the night by sleep stage. From the top teal: heart rate, hot pink: meanNN, gold: HF, red: rMSSD, magenta: LF,
green: LF:HF, blue: SDNN. Mean time of each epoch are as follows; Sleep onset, 2140 SWS1, 2258, SWS2, 2444, REM3, 0139, SWS3, 0240, REM2, 0326, REM1,
0501 (see Table 1 for time standard deviations).
cutaneous vessels is a feature of vasodilation and heat loss (38)
which is evident during sleep onset and during SWS (39) and our
results of low LF and LF:HF in the first SWS cycle may reflect this
vasodilation. LF was increased during pre-sleep and decreased by
half in SWS1. LF stayed low for the first half of the night then
continued to increase incrementally as the night progressed, also
independent of sleep stage. Consistent with our findings, Trinder
et al., showed an abrupt drop in blood pressure during the first
SWS period in healthy young adults (40). The increase in LF
across the night may be an indicator of gradual vasoconstriction
of cutaneous vasculature occurring after a large initial drop in
total peripheral resistance required to activate mechanisms that
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onset deep sleep. The gradual reduction in peripheral vascular
compliance would increase heat conservation and preserve core
temperature as sleep progresses and ambient temperature drops,
regardless of the sleep stage classification. With the exception of
pre-sleep, SDNN followed the same pattern as LF during sleep
and supports the correlation reported by others between the two
variables (33). Furthermore, the significant increase in LF, LF:HF
and SDNN in the REM1 and REM2 coincides with previously
reported increases in heat production in adult males (41) and
REM sleep has been associated with increased vasoconstriction
(41). Heart rate increased and mean NN decreased to almost
pre-sleep levels in these two cycles, however the highest HF (a
potential indicator of parasympathetic drive to cardiac tissue)
was reported to occur in REM2 and REM1 suggesting the
increase in heart rate was not mediated by changes in vagal
innervation. Inhibition to neurons in the rostral raphe and
the RVLM brain stem regions abolishes vasoconstriction to
cutaneous vessels during mild cooling (10). Both the raphe
and the RVLM regions directly control premotor pathways to
cardiac tissue and the baroreflex vasomotor control suggesting
a link between, cardiac function, peripheral vascular control,
and thermoregulation (10). Perhaps the changes in LF, SDNN,
and LF:HF we observed during the REM periods is evidence
of the interrelationship, vascular compliance, cardiac function,
and thermoregulation.
Silvani et al. points out that “the integration between
central and baroreflex drives, which produces the cardiovascular
autonomic outflow, not only differs between wakefulness and
NREM, but also between the two sleep states.” They further
speculate that inconsistences in the relationship between heart
rate, arterial blood pressure, and cardiac output during sleep
arise from changes in vascular compliance (42) suggesting a
possible role for thermoregulation. Our results support this
premise in that, using HRV variables, one can have the same
heart rate/meanNN and very different underlying “autonomic
cardiovascular outflow” (SDNN, LF, HF, rMSSD) throughout the
night and that these autonomic indicators can be different within
the same sleep stage. Given the interrelationship between cardiac
function and vascular motor control, and that elements of HRV
such as LF, SDNN, and LF:HF during sleep in this study may
measure peripheral vasomotor control, sleep maybe an ideal time
to investigate changes in the integrated physiology, e.g., cardiac
activity, vasomotor function, and thermoregulation.
We surmise if LF is a measure of vascular compliance
then our results fit the current model of sleep where LF
picks up vasoconstriction in REM sleep closer to waking and
vasodilation when sleep onsets. Using “uninterrupted” sleep
segments across the night during different sleep stages we
may better understand vascular pathology, particularly in the
pediatric population (43, 44).
Interpreting the Inconsistencies
Our data points to possible inconsistencies in the interpretation
of HRV results during sleep in some previous studies. We
demonstrated that the SDNN prior to sleep onset was the lowest
compared to all the other times recorded, and that this was not
the case with all the other HRV variables. If SDNN is a composite
of SNS and PNS activity (or potentially any other mediator of
cardiac change) why are rMSSD and HF still low and LF still
high at this time? Our results suggest that whatever is driving
changes in SDNN becomes quiescent before the participants
entered sleep and what drives other HRV variables activate once
sleep has onset.
Also, in REM1 and REM2, SDNN, LF, and LF:HF are
significantly increased and HF is the same compared to SWS1
(SDNN, LF, and LF:HF were at their lowest point in the night
in SWS1) yet the heart rates/meanNN were the same, suggesting
whatever caused the higher heart rates (lower meanNN) in
SWS1 and REM periods come from different mechanisms.
Furthermore, why are SDNN, rMSSD, LF and HF similar
during SWS1 and SWS2&3 yet the heart rates/mean NN
significantly different? We postulate two hypotheses. First that
the increased heart rate during this first SWS period may
reflect the increase in concentration of circulating cardiovascular
modifiers [humoral (melatonin/cortisol) and catecholamine],
which are high in the acrophase of the circadian cycle (45–47)
acting directly on cardiac tissue. As time in sleep progresses
these modifiers dissipate and the heart rate reduces revealing the
autonomic input.
Or second, our results in the first SWS cycle may reflect
the effect of increased body temperature on cardiac tissue
conductance (39, 48) independent of neuronal input to the heart
itself as body temperature is at its peak just prior to sleep onset
(acrophase) and is dropping in the first sleep cycle but still
high in the early hours of sleep (12). Cardiac tissue cooling
in rabbits has demonstrated an increase in spontaneous sinus
cycle length, suggesting hotter core temperature alone could
account for the higher heart rate in SWS1 (49). Hence the
lengthening of the cardiac cycle may occur as a bi-product of
somatic cooling. While the increase in heart rate and decrease
in mean NN during REM periods may result from an increase in
cutaneous vasoconstriction that increases vascular resistance and
activation of facultative heating mechanisms that increase body
temperature preparing the brain and organs for arousal from
sleep (10).
The inconsistences in our results may be an example of
“baroreflex resetting” proposed by Dampney as a capacity of
baroreceptors to alter their activation to mediate a proposed
behavior, in this case sleep onset and sleep maintenance (50).
Dampney also highlights that cutaneous vasomotor activation
is less dependent on baroreflex input compared to sympathetic
vasomotor outflows to other vascular beds and hence the
changes in LF we describe may be mediated independent of
the baroreflex and evidence of centrally activated pathways
associated with thermoregulation.
Theoretical Application
It has been proposed that SWS is an ideal time to measure
HRV because of its relative “stability,” with less movement
and regular respiratory patterns (51), however, our data
suggests that not all SWS periods across the night are the
same. The differences between the SWS cycles requires
more investigation to elucidate the parameters (exogenous
e.g., catecholamine levels, vascular compliance, etc.) that
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modulate the cardiac changes. Our results have implication
for studies that measure HRV between groups during the
day. Both circadian and ultradian rhythms affect daytime
body temperature and heart rate, hence data collection
between two different groups (e.g., exercise data) need
to be collected at the same time of day to reduce this
confounding effect.
If LF is an indicator of vascular compliance it may
explain the higher incidents of heart attack (52) and stroke
(53) reported in the mornings in adults. Increased vascular
resistance requires a stronger inotropic output and may
put more pressure on an already compromised system,
hence increasing the probability of cardiac incidences in
the morning. Assessment of pre-wake REM sleep SDNN,
LF, and LF:HF may be prognostic of possible cardiovascular
disease vulnerability.
Our data may also explain the discrepancy between
automating sleep software that use HRV to classify sleep
staging (54, 55). We showed differences in HRV between
cycles that would need to be applied to an algorithm
designed to distinguish sleep stages when only using HRV
changes to define stage differences, such as in the case
of basic smart phone applications and new sleep home
monitoring systems.
Many HRV studies in sleeping children assess the relationship
between age and heart rate variability to measure the “maturation
of the autonomic capacity” (56–58) or to determine HRV
differences in children with disorders affecting cardiac function
such as sleep disordered breathing (59). These studies all yield
different information as the protocol of when to measure
HRV at night are not consistent and most amalgamate and
average data from like stages across the night. The strength
of this study is the large sample number, the consistent and
separated interrogation and comparison of data at similar time
points across the night and wide age range which increases
the likelihood that the findings in this study are robust. Our
results also concur with the suggestion by Scholz et al. that
using the average heart rate over short and long periods
(24 h recordings) of time underestimates autonomic activation
(60). Furthermore it highlights the value in independently
assessing HRV changes using data from uninterrupted sleep
in different cycle across the night. The differences in HRV
variables we have demonstrated across the night may all have
different underlying parallel pathways that equally effect the
way the heart pumps blood around the body. More discrete
analysis of “sleep” HRV may give us better understand of the
role these cardiovascular mediators play in cardiac physiology
and pathology.
One of the challenges of assessing HRV during sleep is
to obtain consistent, artifact free signal over a long period
of time in a specific sleep stage. REM makes up ∼25%
of sleep across the night, with short periods occurring
at the beginning of sleep and bouts of REM increasing
as sleep progresses toward the morning. To maximize
the number of data points and facilitate data analysis we
addressed this limitation by labeling the stages and cycles
as described.
CONCLUSION
Our study has shown that cardiac function during sleep
is significantly modulated by both ultradian and circadian
parameters. Importantly, our findings support the hypothesis
that LF and LF:HF measure vascular compliance via
baroreceptor, and/or centrally controlled factors (e.g.,
temperature control) contingent upon ultradian and circadian
rhythms. Findings from studies that have shown differences
in LF values should be reconsidered in the light of the current
results. There is evidence that some disease states that also affect
cardiovascular function are associated with changes in circadian
and ultradian cycling. Hence, differences in HRV variables
measured throughout the night during different sleep stages
(REM and SWS) may indicate different underlying pathology.
By better understanding their contribution during sleep in
healthy children it may give us better insight into the origin and
treatment of these diseases, many of which begin in childhood.
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